三孔法腹腔镜联合胆道镜保胆取石术的临床应用
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical application of three-port laparoscopic and choledochoscopic gallbladder-preserving cholelithotomy
  • 作者:朱载阳 ; 李英 ; 谭卓林 ; 李鹏泽 ; 田绮俊 ; 潘波 ; 张岚春
  • 英文作者:ZHU Zai-yang;LI Ying;TAN Zhuo-lin;Department of General Surgery,Sichuan Hospital of Integrated Traditional Chinese and Western Medicine;
  • 关键词:胆囊结石病 ; 保胆取石术 ; 腹腔镜检查 ; 胆道镜检查
  • 英文关键词:Cholecystolithiasis;;Gallbladder-preserving cholelithotomy;;Laparoscopy;;Choledochoscopy
  • 中文刊名:FQJW
  • 英文刊名:Journal of Laparoscopic Surgery
  • 机构:四川省中西医结合医院;
  • 出版日期:2014-03-20
  • 出版单位:腹腔镜外科杂志
  • 年:2014
  • 期:v.19
  • 语种:中文;
  • 页:FQJW201403015
  • 页数:4
  • CN:03
  • ISSN:37-1361/R
  • 分类号:51-54
摘要
目的:探讨三孔法腹腔镜联合胆道镜保胆取石术的应用价值、适应证、手术技巧及临床疗效。方法:回顾分析2010年10月至2013年6月96例胆囊结石患者的临床资料,均行三孔法腹腔镜联合胆道镜完全腹腔内微创保胆取石术。结果:96例手术均获成功,无一例中转腹腔镜胆囊切除术或腹腔外微创保胆取石术。术中出血量5~10 ml,平均(6.0±1.1)ml;手术时间98~225 min,平均(121.8±13.2)min。术后无残留结石、出血、胆漏、腹腔感染、胆总管继发结石等并发症发生。术后住院4~7d,平均(4.5±0.6)d,术后1周复查B超,无结石残留。出院后口服熊去氧胆酸、消炎利胆片3~6个月。95例患者随访4~24个月,未见结石复发,无明显消化道症状,术后3个月复查B超提示胆囊收缩功能良好。结论:三孔法腹腔镜联合胆道镜保胆取石术安全、有效,具有患者创伤小、康复快、并发症少、手术成功率高等优点,是微创保胆取石术的理想手术方法,值得推广应用。其关键是把握适应证,术后预防性用药,同时术者需熟练掌握胆道镜技术及腹腔镜下切开、缝合、打结技术。
        Objective: To discuss the clinical value,indications,operative skills and treatment effect of three-port laparoscopic and choledochoscopic gallbladder-preserving cholelithotomy. Methods: The clinical data of 96 patients with gallbladder stones,who underwent three-port mini-invasive preservation of gallbladder and removal of calculi in the peritoneal cavity by laparoscope combined with choledochoscope,from Oct. 2010 to Jun. 2013 were retrospectively analyzed. Results: Three-port total endoscopic minimally invasive gallbladder-preserving cholelithotomy was performed successfully in 96 cases,and no case was converted to laparoscopic cholecystectomy or minimally invasive laparotomy gallbladder-preserving cholelithotomy. Intraoperative blood loss was 5-10 ml,mean( 6. 0 ± 1. 1) ml. The operative time was 98-225 min,mean( 121. 8 ± 13. 2) min. No complications such as residual calculi,hemorrhage,bile leakage,abdominal infection or secondary choledocholith occurred. The postoperative hospital stay was 4-7 d,mean( 4. 5 ± 0. 6) d. B-ultrasonography was performed in 1 week and showed no residual stones. All the patients took ursodeoxycholic acid and Xiaoyan Lidan tablet for 3-6 months postoperatively. 95 patients were followed up from 4 to 24 months,and no recurrence occurred,no obvious digestive tract symptoms were observed. The contractile function of gallbladder was favorable which was evaluated by type-B ultrasonic examination 3 months after surgery. Conclusions: Three-port total endoscopic minimally invasive gallbladder-preserving cholelithotomy is safe,effective,mini-invasive,of quick recovery,has few complications,and a high rate of success,and can be regarded as an ideal operation method for gallbladder-preserving cholelithotomy. The key of the operation should be appropriate selection of cases and preventive using drugs. Furthermore,surgeons should master the skills of choledochoscopy,laparoscopic incision,suture and ligation.
引文
[1]吴在德.外科学[M].5版.北京:人民卫生出版社,2001:618.
    [2]张宝善.胆道外科的治疗进展——内窥镜技术在胆道外科中的应用[J].中国医师进修杂志,2006,29(48):1-3.
    [3]荣万水,刘京山,雷福明,等.胆石症患者不同术式后生存质量调查[J].中国内镜杂志,2010,16(7):685-688.
    [4]张宝善.内镜微创保胆取石术治疗胆囊结石[J].中国内镜杂志,2002,8(7):1-4.
    [5]黄志强.微创外科时代的胆道外科——胆囊切除术尚非平安无事[J].中国实用外科杂志,2011,31(1):1-3.
    [6]张宝善.关于胆囊结石治疗的争论——与langenbuch理论商榷[J].中国医刊,2007,42(5):2-5.
    [7]荣万水,吴建华,曾庆敏,等.胆囊切除与保胆术治疗胆囊结石的比较[J].中国普通外科杂志,2011,20(8):814-817.
    [8]曾宇峰,张阳德,刘蔚东,等.腹腔镜联合胆道镜保胆取石的临床价值[J].中国内镜杂志,2009,15(3):262-264.
    [9]李全福,葛长青,张阳德,等.腹腔镜辅助与小切口微创保胆手术的对照研究[J].腹腔镜外科杂志,2011,16(3):205-207.
    [10]丘敏梅,易石坚,刘兆云,等.腹腔镜联合胆道镜保胆手术的临床研究[J].中国内镜杂志,2009,15(8):883-888.
    [11]刘建辉,邵青龙,魏银江,等.腹腔镜联合胆道镜保胆取石术的临床研究[J].中国普通外科杂志,2009,18(8):877-879.
    [12]章丽娟.中国胆石症危险因素的流行病学研究[J].医学信息,2009,22(12):2979-2982.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.